95% OR | ||
---|---|---|
In-championship injury | ||
Simple models | Multiple model | |
Sex | NS | |
Age | NS | |
Continent (reference Europe) | NS | |
Africa | NS | |
Asia | NS | |
Australia | NS | |
North America | NS | |
South America | NS | |
Event category (reference speed/power) Endurance (Middle and long distance running, marathon, race walking) | NS | |
Prechampionships medical support available | NS | |
Preparticipation health symptoms | ||
Injury symptoms | ||
Reduced participation | NS | |
Gradual-onset | 3.19 (1.14 to 8.94) (p=0.027) | 3.09 (1.08 to 8.79) (p=0.035) |
Severity score | 2.78 (1.01 to 7.66) (p=0.048) | |
Notable duration (>2 days) | NS* | |
Anxiety caused | NS** | |
Expected impact at championships | NS | |
Illness symptoms | ||
Reduced participation | NS | |
Severity score | NS | |
Notable duration (>2 days) | 4.08 (1.21 to 13.70) (p=0.023) | |
Anxiety caused | 5.87 (1.46 to 23.64) (p=0.013) | 5.56 (1.34 to 23.15) (p=0.018) |
*p=0.060; **p=0.081.
NS, not significant.